Global Cord Blood Corporation (CO)
| Market Cap | 284.43M |
| Revenue (ttm) | 195.06M |
| Net Income (ttm) | 81.89M |
| Shares Out | 121.55M |
| EPS (ttm) | 0.65 |
| PE Ratio | 3.61 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 185,549 |
| Open | 2.48 |
| Previous Close | 2.53 |
| Day's Range | 2.25 - 2.54 |
| 52-Week Range | 2.10 - 6.31 |
| Beta | 0.39 |
| Analysts | Buy |
| Price Target | n/a |
| Earnings Date | Jun 27, 2022 |
About CO
Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2021, it operated three cord blood banks in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China ...
Financial Performance
In 2020, CO's revenue was 1.16 billion, a decrease of -5.06% compared to the previous year's 1.22 billion. Earnings were 508.25 million, an increase of 7.97%.
Financial numbers in millions CNYFinancial StatementsNews
Blue Ocean Comments on Fraudulent Claims from Conflicted Party Golden Meditech Regarding Global Cord Blood Corporation
NEW YORK--(BUSINESS WIRE)--Blue Ocean Structure Investment Company Ltd. (“Blue Ocean”), a significant shareholder of Global Cord Blood Corporation (the “Company” or “Global Cord”) (NYSE: CO), today comm...
Global Cord Blood Corporation Announces Receipt of Blue Ocean Petition
HONG KONG , May 10, 2022 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO, "GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell...
3 Hot Penny Stocks to Buy in Q1 for Huge Potential
3 penny stocks to consider buying as they are undervalued, have low levels of debt and strong anticipated EPS growth. The post 3 Hot Penny Stocks to Buy in Q1 for Huge Potential appeared first on Invest...
Global Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2022
Added 18,985 New Subscribers in 3Q22 Revenues Up 9.1% YoY to RMB317.2 Million ($49.8 Million) Gross Profit Up 9.8% YoY to RMB269.9 Million ($42.4 Million) Operating Income Up 20.8% YoY to RMB149...
Global Cord Blood Corporation to Report Third Quarter and First Nine Months Fiscal 2022 Financial Results
HONG KONG, Feb. 23, 2022 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processi...
Global Cord Blood Corporation Announces Rejection of Alternate Ocean Proposal
HONG KONG, Dec. 16, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cel...
Global Cord Blood Corporation Announces Results of 2021 Annual General Meeting
HONG KONG, Dec. 7, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell...
Global Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2022
Added 19,066 New Subscribers in 2Q22 Revenues Up 9.8% YoY to RMB313.7 Million ($48.7 Million) Gross Profit Up 11.0% YoY to RMB267.5 Million ($41.5 Million) Operating Income Up 15.3% YoY to RMB16...
Global Cord Blood Corporation to Report Second Quarter and First Half Fiscal 2022 Financial Results
HONG KONG, Nov. 17, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processi...
Global Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on December 7, 2021
HONG KONG , Sept. 17, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem c...
Global Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2022
1Q22 Added 19,673 New Subscribers Revenues Up 12.2% YoY to RMB315.2 Million ($48.8 Million) Gross Profit Up 12.6% YoY to RMB267.3 Million ($41.4 Million) Operating Income Up 17.3% YoY to RMB156.6 Millio...
Global Cord Blood Corporation to Report First Quarter Fiscal 2022 Financial Results
HONG KONG, Aug. 25, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processi...
Global Cord Blood Corporation Files Annual Report on Form 20-F
HONG KONG, July 29, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cel...
Global Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2021
Added 19,367 New Subscribers in 4Q21 Revenues Up 0.8% YoY to RMB302.3 million ($46.1 million) Net Income Attributable Up 31.7% YoY to RMB127.7 million ($19.5 million) Operating Cash Flow Up 134.6% YoY t...
Global Cord Blood Corporation to Report Fourth Quarter and Full Year Fiscal 2021 Financial Results
HONG KONG, June 22, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processi...
Global Cord Blood Corporation Announces Formation of a Special Committee to Evaluate Non-Binding Proposal
HONG KONG, March 15, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem ce...
Why Global Cord Blood Corporation Stock Is Jumping Today
The company received an acquisition offer.
Global Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2021
HONG KONG, Feb. 24, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cel...
Global Cord Blood Corporation to Report Third Quarter and First Nine Months Fiscal 2021 Financial Results
HONG KONG, Feb. 19, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processi...
Global Cord Blood Announces NHC Policy Update
HONG KONG, Jan. 5, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processin...
Global Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2021
HONG KONG, Nov. 24, 2020 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cel...
3 Stocks That Could Be Deals
Investors who are screening for value opportunities may want to consider the following stocks since their share prices are trading at a discount to the intrinsic value calculated by GuruFocus' earnings-...
Global Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on December 7, 2020
HONG KONG, Sept. 17, 2020 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem ce...
Global Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2021
HONG KONG, Aug. 24, 2020 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cel...
Global Cord Blood Corporation Files Its Annual Report on Form 20-F
HONG KONG, July 29, 2020 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cel...